Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection.
Drummer HE, Van H, Klock E, Zheng S, Wei Z, Boo I, Center RJ, Li F, Bhat P, Ffrench R, Lau JS, McMahon J, Laeyendecker O, Fernandez RE, Manabe YC, Klein SL, Quinn TC, Anderson DA. Drummer HE, et al. Among authors: manabe yc. medRxiv [Preprint]. 2021 Jul 1:2021.06.28.21259671. doi: 10.1101/2021.06.28.21259671. medRxiv. 2021. PMID: 34230936 Free PMC article. Preprint.
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses.
Pisanic N, Antar AAR, Kruczynski K, Rivera MG, Dhakal S, Spicer K, Randad PR, Pekosz A, Klein SL, Betenbaugh MJ, Detrick B, Clarke W, Thomas DL, Manabe YC, Heaney CD. Pisanic N, et al. Among authors: manabe yc. medRxiv [Preprint]. 2022 Dec 26:2022.12.22.22283858. doi: 10.1101/2022.12.22.22283858. medRxiv. 2022. PMID: 36597525 Free PMC article. Updated. Preprint.
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection.
Smith RL, Gibson LL, Martinez PP, Ke R, Mirza A, Conte M, Gallagher N, Conte A, Wang L, Fredrickson R, Edmonson DC, Baughman ME, Chiu KK, Choi H, Jensen TW, Scardina KR, Bradley S, Gloss SL, Reinhart C, Yedetore J, Owens AN, Broach J, Barton B, Lazar P, Henness D, Young T, Dunnett A, Robinson ML, Mostafa HH, Pekosz A, Manabe YC, Heetderks WJ, McManus DD, Brooke CB. Smith RL, et al. Among authors: manabe yc. medRxiv [Preprint]. 2021 Mar 22:2021.03.19.21253964. doi: 10.1101/2021.03.19.21253964. medRxiv. 2021. PMID: 33791719 Free PMC article. Updated. Preprint.
Daily sampling of early SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness.
Ke R, Martinez PP, Smith RL, Gibson LL, Mirza A, Conte M, Gallagher N, Luo CH, Jarrett J, Conte A, Liu T, Farjo M, Walden KKO, Rendon G, Fields CJ, Wang L, Fredrickson R, Edmonson DC, Baughman ME, Chiu KK, Choi H, Scardina KR, Bradley S, Gloss SL, Reinhart C, Yedetore J, Quicksall J, Owens AN, Broach J, Barton B, Lazar P, Heetderks WJ, Robinson ML, Mostafa HH, Manabe YC, Pekosz A, McManus DD, Brooke CB. Ke R, et al. Among authors: manabe yc. medRxiv [Preprint]. 2021 Jul 12:2021.07.12.21260208. doi: 10.1101/2021.07.12.21260208. medRxiv. 2021. PMID: 34282424 Free PMC article. Updated. Preprint.
Longitudinal analysis of SARS-CoV-2 vaccine breakthrough infections reveal limited infectious virus shedding and restricted tissue distribution.
Ke R, Martinez PP, Smith RL, Gibson LL, Achenbach CJ, McFall S, Qi C, Jacob J, Dembele E, Bundy C, Simons LM, Ozer EA, Hultquist JF, Lorenzo-Redondo R, Opdycke AK, Hawkins C, Murphy RL, Mirza A, Conte M, Gallagher N, Luo CH, Jarrett J, Conte A, Zhou R, Farjo M, Rendon G, Fields CJ, Wang L, Fredrickson R, Baughman ME, Chiu KK, Choi H, Scardina KR, Owens AN, Broach J, Barton B, Lazar P, Robinson ML, Mostafa HH, Manabe YC, Pekosz A, McManus DD, Brooke CB. Ke R, et al. Among authors: manabe yc. medRxiv [Preprint]. 2021 Sep 2:2021.08.30.21262701. doi: 10.1101/2021.08.30.21262701. medRxiv. 2021. PMID: 34494028 Free PMC article. Updated. Preprint.
Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts.
Robinson ML, Mirza A, Gallagher N, Boudreau A, Garcia L, Yu T, Norton J, Luo CH, Conte A, Zhou R, Kafka K, Hardick J, McManus DD, Gibson LL, Pekosz A, Mostafa H, Manabe YC. Robinson ML, et al. Among authors: manabe yc. medRxiv [Preprint]. 2022 Feb 7:2022.02.05.22270481. doi: 10.1101/2022.02.05.22270481. medRxiv. 2022. PMID: 35169814 Free PMC article. Updated. Preprint.
Divergent Neuroimmune Signatures in the Cerebrospinal Fluid Predict Differential Gender-Specific Survival Among Patients With HIV-Associated Cryptococcal Meningitis.
Okurut S, Boulware DR, Okafor E, Rhein J, Kajumbula H, Bagaya B, Bwanga F, Olobo JO, Manabe YC, Meya DB, Janoff EN; ASTRO trial team. Okurut S, et al. Among authors: manabe yc. medRxiv [Preprint]. 2023 Aug 15:2023.08.09.23293903. doi: 10.1101/2023.08.09.23293903. medRxiv. 2023. PMID: 37645984 Free PMC article. Updated. Preprint.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Shah NS, Kityo C, Hughes MD, McCarthy C, Wallis C, Hosseinipour M, Langat D, Nyirenda M, Rassool M, Dawson R, Joseph Y, Some F, Mngqbisa R, Mukwekwerere PG, Woolley E, Godfrey C, Manabe YC, Mellors JW, Flexner C, Maartens G; ACTG A5381/Hakim Study Team. Shah NS, et al. Among authors: manabe yc. Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093/cid/ciae269. Online ahead of print. Clin Infect Dis. 2024. PMID: 38739755
299 results